Day 1 of updates from the annual HD Therapeutics Conference in Palm Springs
Antibodies are known for their role in immunity, but researchers repurpose them in many ways. Can they be used in HD?
HD drug changes DNA folding across generations
Weighing the scales on mTORC1: A possible new target for HD therapeutics?
A new study shows a synthetic oil called triheptanoin changes how HD brains use energy. But will it help HD?
Modified 'heavy hydrogen' form of tetrabenazine appears safe and effective for chorea in Huntington's disease
Scientists can now change human skin cells into working neurons, like the ones that are most affected in HD.
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
CREST-E, a trial of the supplement creatine, has been stopped after an early analysis found it couldn't show benefit
Cool lab experiments show the huntington's disease protein jumping between cells. Does this matter for HD patients?
Video of our first live session at the European Huntington's Disease Network Meeting.